Novanta, Inc. (NOVT)
134.43
-2.21
(-1.62%)
USD |
NASDAQ |
Feb 27, 16:00
130.64
-3.79
(-2.82%)
Pre-Market: 20:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.809B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -7.50% |
| Valuation | |
| PE Ratio | 92.14 |
| PE Ratio (Forward) | |
| PS Ratio | 5.036 |
| Price to Book Value | 3.659 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 0.2303 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 46.71% |
Profile
| Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment enagages in the designing, manufacturing and marketing of laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles to customers worldwide. The Medical Solutions segment is involved in the designing, manufacturing and marketing of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded in 1968 and is headquartered in Bedford, MA. |
| URL | http://www.novanta.com |
| Investor Relations URL | https://investors.novanta.com |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Next Earnings Release | May. 05, 2026 (est.) |
| Last Earnings Release | Feb. 23, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment enagages in the designing, manufacturing and marketing of laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles to customers worldwide. The Medical Solutions segment is involved in the designing, manufacturing and marketing of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded in 1968 and is headquartered in Bedford, MA. |
| URL | http://www.novanta.com |
| Investor Relations URL | https://investors.novanta.com |
| HQ State/Province | Massachusetts |
| Sector | Information Technology |
| Industry | Electronic Equipment, Instruments & Components |
| Next Earnings Release | May. 05, 2026 (est.) |
| Last Earnings Release | Feb. 23, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |